Literature DB >> 7674130

Comparison of body distribution of poly(vinyl alcohol) with other water-soluble polymers after intravenous administration.

T Yamaoka1, Y Tabata, Y Ikada.   

Abstract

The body distribution of poly(vinyl alcohol) (PVA) with molecular weights (MW) from 14,800 to 434,000 Da was investigated after intravenous administration and compared with that of other water-soluble polymers such as poly(ethylene glycol) (PEG), gelatin, dextran, and pullulan. The half-life of PVA in the circulation was prolonged from 90 min (MW 14,800 Da) to 23 h (MW 434,000 Da), similar to that of PEG which had a half-life of 30 min (MW 6000) and 20 h (MW 170,000). However, the half-life of PVA was much longer than that of other polymers when compared at a similar molecular weight. PVA was located in most organs but with very small accumulation. An insignificant interaction of PVA with cell components, such as macrophages and blood cells, was observed. Similar to PEG, the excretion rate of PVA at the glomeruli was rapidly reduced around 30,000 Da, as the molecular weight increased. These results indicate that the half-life of intravenously injected PVA in the blood was mainly determined by the permeation characteristics of the kidney.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7674130     DOI: 10.1111/j.2042-7158.1995.tb05835.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  18 in total

1.  Synthesis, neutralization and blocking procedures of organic/inorganic hybrid scaffolds for bone tissue engineering applications.

Authors:  Hermes S Costa; Edel F B Stancioli; Marivalda M Pereira; Rodrigo L Oréfice; Herman S Mansur
Journal:  J Mater Sci Mater Med       Date:  2008-09-20       Impact factor: 3.896

2.  Novel bioresorbable and bioeliminable surfactants for microsphere preparation.

Authors:  P Bouillot; V Babak; E Dellacherie
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

3.  Liver targeting of interferon through pullulan conjugation.

Authors:  K Xi; Y Tabata; K Uno; M Yoshimoto; T Kishida; Y Sokawa; Y Ikada
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

4.  Evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in Hep G2 cell line.

Authors:  Swati A Guhagarkar; Sharmila B Majee; Abdul Samad; Padma V Devarajan
Journal:  Cancer Nanotechnol       Date:  2011-01-27

5.  Controlling the kinetic chain length of the crosslinks in photo-polymerized biodegradable networks.

Authors:  Janine Jansen; Abdul Ghaffar; Thomas N S van der Horst; George Mihov; Sjoerd van der Wal; Jan Feijen; Dirk W Grijpma
Journal:  J Mater Sci Mater Med       Date:  2013-01-31       Impact factor: 3.896

Review 6.  Absorption, distribution, metabolism, and excretion (ADME) studies of biotherapeutics for autoimmune and inflammatory conditions.

Authors:  Yulia Vugmeyster; John Harrold; Xin Xu
Journal:  AAPS J       Date:  2012-07-14       Impact factor: 4.009

7.  Encapsulation of poorly soluble drugs in polymer-drug conjugates: effect of dual-drug nanoformulations on cancer therapy.

Authors:  Thulani H Senanayake; Yaman Lu; Anna Bohling; Srikumar Raja; Hamid Band; Serguei V Vinogradov
Journal:  Pharm Res       Date:  2014-01-23       Impact factor: 4.200

8.  Polymer conjugated retinoids for controlled transdermal delivery.

Authors:  Steven A Castleberry; Mohiuddin A Quadir; Malak Abu Sharkh; Kevin E Shopsowitz; Paula T Hammond
Journal:  J Control Release       Date:  2017-07-06       Impact factor: 9.776

9.  Application of activated nucleoside analogs for the treatment of drug-resistant tumors by oral delivery of nanogel-drug conjugates.

Authors:  Thulani H Senanayake; Galya Warren; Xin Wei; Serguei V Vinogradov
Journal:  J Control Release       Date:  2013-02-04       Impact factor: 9.776

10.  A prospective, randomised, controlled, double-blind phase I-II clinical trial on the safety of A-Part Gel as adhesion prophylaxis after major abdominal surgery versus non-treated group.

Authors:  Reinhold Lang; Petra Baumann; Karl-Walter Jauch; Claudia Schmoor; Christine Weis; Erich Odermatt; Hanns-Peter Knaebel
Journal:  BMC Surg       Date:  2010-07-06       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.